CN103705457B - 含盐酸沃尼妙林/聚乙二醇载药微粒的油质注射剂 - Google Patents
含盐酸沃尼妙林/聚乙二醇载药微粒的油质注射剂 Download PDFInfo
- Publication number
- CN103705457B CN103705457B CN201410007630.1A CN201410007630A CN103705457B CN 103705457 B CN103705457 B CN 103705457B CN 201410007630 A CN201410007630 A CN 201410007630A CN 103705457 B CN103705457 B CN 103705457B
- Authority
- CN
- China
- Prior art keywords
- solid
- peg
- preparation
- injection
- valnemulin hydrochloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920001223 polyethylene glycol Polymers 0.000 title claims abstract description 73
- 239000002202 Polyethylene glycol Substances 0.000 title claims abstract description 61
- 239000003814 drug Substances 0.000 title claims abstract description 53
- 238000002347 injection Methods 0.000 title claims abstract description 48
- 239000007924 injection Substances 0.000 title claims abstract description 48
- 239000004531 microgranule Substances 0.000 title claims abstract description 39
- LLYYNOVSVPBRGV-MVNKZKPCSA-N valnemulin Chemical compound CC(C)[C@@H](N)C(=O)NCC(C)(C)SCC(=O)O[C@@H]1C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@@]23CC[C@@H](C)[C@]1(C)[C@@H]2C(=O)CC3 LLYYNOVSVPBRGV-MVNKZKPCSA-N 0.000 title claims abstract description 19
- 229950008166 valnemulin Drugs 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 claims abstract description 58
- MFBPRQKHDIVLOJ-AFFLPQGKSA-N 133868-46-9 Chemical compound Cl.CC(C)[C@@H](N)C(=O)NCC(C)(C)SCC(=O)O[C@@H]1C[C@@](C)(C=C)[C@@H](O)[C@H](C)[C@@]23CC[C@@H](C)[C@]1(C)[C@@H]2C(=O)CC3 MFBPRQKHDIVLOJ-AFFLPQGKSA-N 0.000 claims abstract description 56
- 239000007787 solid Substances 0.000 claims abstract description 35
- 239000003921 oil Substances 0.000 claims abstract description 30
- 235000019198 oils Nutrition 0.000 claims abstract description 30
- -1 hydroxypropyl Chemical group 0.000 claims abstract description 7
- 210000000582 semen Anatomy 0.000 claims abstract description 6
- 235000012424 soybean oil Nutrition 0.000 claims abstract description 5
- 239000003549 soybean oil Substances 0.000 claims abstract description 5
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims abstract 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 45
- 239000006104 solid solution Substances 0.000 claims description 30
- 239000002245 particle Substances 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000084 colloidal system Substances 0.000 claims description 10
- 239000004576 sand Substances 0.000 claims description 10
- 238000009472 formulation Methods 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 4
- 239000010419 fine particle Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 229920002538 Polyethylene Glycol 20000 Polymers 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000013019 agitation Methods 0.000 claims description 2
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 238000007711 solidification Methods 0.000 claims description 2
- 230000008023 solidification Effects 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 5
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 5
- 125000003827 glycol group Chemical group 0.000 claims 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000000155 melt Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 241000282898 Sus scrofa Species 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 208000001572 Mycoplasma Pneumonia Diseases 0.000 description 1
- 201000008235 Mycoplasma pneumoniae pneumonia Diseases 0.000 description 1
- 241000204003 Mycoplasmatales Species 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000000227 bioadhesive Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000007908 nanoemulsion Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 238000005381 potential energy Methods 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410007630.1A CN103705457B (zh) | 2014-01-08 | 2014-01-08 | 含盐酸沃尼妙林/聚乙二醇载药微粒的油质注射剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410007630.1A CN103705457B (zh) | 2014-01-08 | 2014-01-08 | 含盐酸沃尼妙林/聚乙二醇载药微粒的油质注射剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103705457A CN103705457A (zh) | 2014-04-09 |
CN103705457B true CN103705457B (zh) | 2016-03-16 |
Family
ID=50399054
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410007630.1A Active CN103705457B (zh) | 2014-01-08 | 2014-01-08 | 含盐酸沃尼妙林/聚乙二醇载药微粒的油质注射剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103705457B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1533764A (zh) * | 2003-04-02 | 2004-10-06 | 王玉万 | 含非甾体抗炎药物的缓释注射剂 |
CN1565470A (zh) * | 2003-07-10 | 2005-01-19 | 王玉万 | 含道拉菌素类抗寄生虫药物的长效注射剂 |
CN102119919A (zh) * | 2011-03-10 | 2011-07-13 | 青岛科技大学 | 一种沃尼妙林油性注射剂的制备方法 |
-
2014
- 2014-01-08 CN CN201410007630.1A patent/CN103705457B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1533764A (zh) * | 2003-04-02 | 2004-10-06 | 王玉万 | 含非甾体抗炎药物的缓释注射剂 |
CN1565470A (zh) * | 2003-07-10 | 2005-01-19 | 王玉万 | 含道拉菌素类抗寄生虫药物的长效注射剂 |
CN102119919A (zh) * | 2011-03-10 | 2011-07-13 | 青岛科技大学 | 一种沃尼妙林油性注射剂的制备方法 |
Non-Patent Citations (1)
Title |
---|
盐酸头孢噻呋混悬注射液制备工艺和稳定性研究;胡兴平;《中国优秀硕士学位论文全文数据库 农业科技辑》;20090915;D050-235 * |
Also Published As
Publication number | Publication date |
---|---|
CN103705457A (zh) | 2014-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105055319A (zh) | 一种氟苯尼考可溶性粉及其制备方法 | |
CN105748408A (zh) | 微乳、微乳制剂及其制备方法 | |
CN103705454B (zh) | 含盐酸沃尼妙林/泊洛沙姆407的油质注射剂 | |
CN103705452B (zh) | 含泊洛沙姆407和油性介质的抗菌药物注射剂 | |
Bhowmik et al. | Solid dispersion-a approach to enhance the dissolution rate of poorly water soluble drugs | |
CN104721155A (zh) | 一种替莫唑胺冻干粉制剂及其制备方法 | |
CN103720652B (zh) | 用泊洛沙姆和油性介质制备含阿维菌素类药物注射剂 | |
CN103768014A (zh) | 含泰拉霉素/泊洛沙姆407的油质注射剂 | |
CN103536530A (zh) | 盐酸多西环素长效注射剂及制备方法 | |
CN105748437A (zh) | 囊泡、囊泡制剂及其制备方法 | |
CN104490762B (zh) | 一种氨甲环酸外用半固体制剂及制备方法 | |
CN103721263A (zh) | 含抗菌药物/聚乙二醇载药微粒的油质注射剂 | |
CN103705457B (zh) | 含盐酸沃尼妙林/聚乙二醇载药微粒的油质注射剂 | |
CN103550149A (zh) | 含抗寄生虫药物长效注射剂的制备技术 | |
CN102429918A (zh) | 一种含有氟苯尼考和茶皂素的药物组合物及其制备方法 | |
CN103550150B (zh) | 改进的含二甲基硅油的注射剂 | |
CN103705456A (zh) | 含延胡索酸泰妙菌素/聚乙二醇载药微粒的油质注射剂 | |
CN102058545A (zh) | 一种注射用美罗培南冻干制剂及其制备方法 | |
CN103520099A (zh) | 含有效成份为沃尼妙林的长效注射剂 | |
CN103705453B (zh) | 含盐酸多西环素/泊洛沙姆载药微粒的油质注射剂 | |
CN103432074B (zh) | 吡喹酮乳剂注射液及其制备工艺 | |
CN105832744A (zh) | 一种供注射用的前列地尔冻干乳剂组合物 | |
CN103721260A (zh) | 含抗寄生虫药/聚乙二醇载药微粒的油质注射剂 | |
CN103520098A (zh) | 恩诺沙星兽用长效注射剂的制备方法 | |
CN103536529A (zh) | 含头孢噻呋长效注射剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170103 Address after: 102206 Haidian District information road, Beijing, No. 28 on the information building, floor B4-2, four Patentee after: Beijing Zhongnonghuawei Biological Technology Co.,Ltd. Address before: 100083 Beijing Qinghua East Road, No. 17,, 41-5-102 Patentee before: Wang Yuwan |
|
DD01 | Delivery of document by public notice |
Addressee: Beijing Zhongnonghuawei Biological Technology Co.,Ltd. Document name: Notification of Passing Examination on Formalities |
|
DD01 | Delivery of document by public notice | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240321 Address after: 435300 Jinshan Road, Hexi Lishizhen Pharmaceutical Industrial Park, Qichun County, Huanggang City, Hubei Province, No. 008-8 Patentee after: Hubei Shizhen Health Research Co.,Ltd. Country or region after: Zhong Guo Address before: B4-2, 4th Floor, Shangdi Information Building, No. 28 Xinxin Road, Haidian District, Beijing, 102206 Patentee before: Beijing Zhongnonghuawei Biological Technology Co.,Ltd. Country or region before: Zhong Guo |
|
TR01 | Transfer of patent right |